RxDoctor Payments Data

Patrick Chen, DO

Gastroenterology · Columbus, OHNPI 1265859243

Payments from drug & device makers

$29,114in general payments, 2019–2025

Across 153 payments — averaging $190.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$14K
  • Sanofi$9K
  • AbbVie$3K
  • E.r. Squibb & Sons, L.L.C.$475
  • Boston Scientific$472
  • Pfizer$344
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$8,35629%
  • Speaking & faculty fees$11,97041%
  • Travel & lodging$5462%
  • Food & beverage$7,08224%
  • Education$1,1604%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,114 in reported general payments places this provider in the 80th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$68,361
Medicare patients
342
Services billed
501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SucraidSacrosidase11$125,176
CreonLipase/Protease/Amylase18$55,384
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg208$3,967
Omeprazole162$1,808
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl64$833
Pantoprazole Sodium44$773
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl14$216
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl14$210
Famotidine14$94

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
QOL Medical, LLCSucraid$298$125,17611 claims
AbbVieCreon$2,646$55,38418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →